Elizabeth M. Anderson, Director at Revolution Medicines, Inc. (RVMD), sold 10,143 shares at $191.85 ($2.0M) on 2026-09-22, disclosed to the SEC on 2026-09-24.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $191.85 | 910 | $175K | 8.9% |
| 2 | $192.54 | 4,985 | $960K | 49.0% |
| 3 | $193.44 | 2,648 | $512K | 26.2% |
| 4 | $194.59 | 1,500 | $292K | 14.9% |
| 5 | $195.15 | 100 | $20K | 1.0% |
| Total | $193.04 avg | 10,143 |
| $2.0M |
| 100% |
| Filing → |
| RVMD | SELL | 2020-10-15 | $225K | — | Filing → |
| RVMD | SELL | 2020-10-08 | $200K | — | Filing → |